Canada· CA-DIN-02495848

DRAX EXAMETAZIME

A medicinal product containing exametazime, registered in Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA.

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedDRAX EXAMETAZIMEATC—REGISTER NO.CA-DIN-02495848PACKS LISTED0CHECKEDOctober 1, 2026

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
EXAMETAZIME
Manufacturer
JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Country
Canada (CA)
ATC code
—
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Exametazime in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exametazime products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Medi-Exametazim
  • Belgium · Exametazime Radiopharmacy Laboratory, Stabilised Ceretec
  • Czechia · Brain - Spect Kit, Exametazim Radiopharmacy Laboratorium
  • Germany · Medi-Exametazim
  • Denmark · Ceretec, Medi-Exametazim
  • Spain · Ceretec, Ceretec Estabilizado
  • Finland · Ceretec
  • France · Cerestab, Ceretec
  • United Kingdom (Northern Ireland) · Ceretec, Stabilised Ceretec
  • Greece · Ceretec
  • Hungary · Brain-Spect, Ceretec
  • Italy · Ceretec, Exametascan
  • Lithuania · Ceretec
  • Luxembourg · Medi-Exametazim, Stabilised Ceretec
  • Netherlands · Ceretec, Exametazime Radiopharmacy Laboratory
  • Norway · Ceretec, Exametazime Radiopharmacy Laboratory
  • Portugal · Exametazima Radiopharmacy
  • Sweden · Ceretec Stabilised, Exametazim Radiopharmacy Laboratory
  • Slovenia · Eksametazim Radiopharmacy Laboratory
  • Slovakia · Ceretec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/165feba0-9e34-4d1b-80ae-1e18fc7a9696
GET /v1/drugs/165feba0-9e34-4d1b-80ae-1e18fc7a9696?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02495848",
  "form": "POWDER FOR SOLUTION",
  "class": "Radiopharmaceutical",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": null,
  "schedule": [
    "Schedule C"
  ],
  "drug_code": "98574",
  "strengths": [
    "0.5 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "EXAMETAZIME"
  ],
  "product_categorization": null
}

See everything about exametazime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.